ArticleLiver cancer2026

Immune Checkpoint Inhibitor Rechallenge in Unresectable Hepatocellular Carcinoma: A Multicenter Efficacy and Safety Study.

Jing-Kun Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.